Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

  title={Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.},
  author={Zachary D. Goodman and Hala R. Makhlouf and Lea Liu and William F. Balistreri and Regino P. Gonz{\'a}lez-Peralta and Barbara A Haber and Maureen M. Jonas and Parvathi Mohan and Jean Pappas Molleston and Karen F. Murray and Michael R. Narkewicz and Philip John Rosenthal and Lesley J Smith and Patricia R Robuck and Kathleen B. Schwarz},
  volume={47 3},
There is relatively little information in the literature on the histopathology of chronic hepatitis C in children. The Peds-C Trial, designed to test the efficacy and safety of peginterferon alfa-2a and ribavirin in children, provided an opportunity to examine liver biopsies from 121 treatment-naïve children, ages 2 to 16 (mean, 9.8 years) infected with the hepatitis C virus (HCV) and with no other identifiable cause for liver disease, signs of hepatic decompensation, or another significant… CONTINUE READING
57 Citations
27 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 57 extracted citations


Publications referenced by this paper.
Showing 1-10 of 27 references

Maddrey WC, eds: Schiff’s diseases of the liver, 10th ed

  • ASF Lok, HS Conjeevaram, B Negro F. Hepatitis, ER D. In Schiff, MF Sorrell
  • 2007

Similar Papers

Loading similar papers…